Intracerebral hemorrhage following intravenous thrombolysis in Thai patients with acute ischemic stroke

被引:15
作者
Dharmasaroja, Pornpatr A. [1 ]
Muengtaweepongsa, Sombat [1 ]
Pattaraarchachai, Junya [2 ]
Dharmasaroja, Permphan [3 ]
机构
[1] Thammasat Univ, Fac Med, Dept Internal Med, Div Neurol, Klongluang 12120, Pathumthani, Thailand
[2] Thammasat Univ, Fac Med, Dept Community Med, Data Anal & Management Unit, Klongluang 12120, Pathumthani, Thailand
[3] Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10700, Thailand
关键词
Asia; Intracranial hemorrhage; Stroke; Thai; Thrombolysis; TISSUE-PLASMINOGEN ACTIVATOR; SCIENTIFIC STATEMENT; CLINICAL-PRACTICE; CONTROLLED-TRIAL; EARLY MANAGEMENT; ECASS II; ALTEPLASE; ASSOCIATION; THERAPY; IMPLEMENTATION;
D O I
10.1016/j.jocn.2011.08.035
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Asia, there is limited information regarding symptomatic intracerebral hemorrhage (ICH) in patients treated with intravenous (iv) recombinant tissue plasminogen activator (rtPA). The aim of this study was to identify independent factors associated with symptomatic ICH following iv rtPA. The study included 192 patients with acute ischemic stroke who were treated with iv rtPA. Baseline characteristics were compared between patients with or without ICH. Symptomatic ICH occurred in 5.7% of patients and asymptomatic ICH in 13.0% of patients. An international normalized ratio (INR) >= 1.0 (odds ratio [OR] = 4.89, p = 0.036), atrial fibrillation (OR = 7.21, p = 0.009) and blood glucose concentration >8.325 mmol/L (OR = 9.00, p = 0.004), were independent risk factors for symptomatic ICH. Atrial fibrillation (OR = 3.56, p = 0.012) and severe stroke (National Institutes of Health Stroke Scale >= 15 OR = 8.94, p < 0.001) were independent risk factors for asymptomatic ICH. The prevalence of symptomatic ICH following iv rtPA in Thai patients was comparable to previous studies. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:799 / 803
页数:5
相关论文
共 20 条
[1]   Guidelines for the Early Management of Patients With Ischemic Stroke - 2005 guidelines update - A scientific statement from the Stroke Council of the American Heart Association/American Stroke Association [J].
Adams, H ;
Adams, R ;
Del Zoppo, G ;
Goldstein, LB .
STROKE, 2005, 36 (04) :916-923
[2]   Guidelines for the early management of patients with ischemic stroke - A scientific statement from the Stroke Council of the American Stroke Association [J].
Adams, HP ;
Adams, RJ ;
Brott, T ;
del Zoppo, GJ ;
Furlan, A ;
Goldstein, LB ;
Grubb, RL ;
Higashida, R ;
Kidwell, C ;
Kwiatkowski, TG ;
Marler, JR ;
Hademenos, GJ .
STROKE, 2003, 34 (04) :1056-1083
[3]   Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke [J].
Brott, T ;
Broderick, J ;
Kothari, R ;
ODonoghue, M ;
Barsan, W ;
Tomsick, T ;
Spilker, J ;
Miller, R ;
Sauerbeck, L ;
Farrell, J ;
Kelly, J ;
Perkins, T ;
Miller, R ;
McDonald, T ;
Rorick, M ;
Hickey, C ;
Armitage, J ;
Perry, C ;
Thalinger, K ;
Rhude, R ;
Schill, J ;
Becker, PS ;
Heath, RS ;
Adams, D ;
Reed, R ;
Klei, M ;
Hughes, A ;
Anthony, J ;
Baudendistel, D ;
Zadicoff, C ;
Rymer, M ;
Bettinger, I ;
Laubinger, P ;
Schmerler, M ;
Meiros, G ;
Lyden, P ;
Dunford, J ;
Zivin, J ;
Rapp, K ;
Babcock, T ;
Daum, P ;
Persona, D ;
Brody, M ;
Jackson, C ;
Lewis, S ;
Liss, J ;
Mahdavi, Z ;
Rothrock, J ;
Tom, T ;
Zweifler, R .
STROKE, 1997, 28 (11) :2109-2118
[4]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[5]   Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association [J].
del Zoppo, Gregory J. ;
Saver, Jeffrey L. ;
Jauch, Edward C. ;
Adams, Harold P., Jr. .
STROKE, 2009, 40 (08) :2945-2948
[6]   Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke [J].
Demchuk, AM ;
Morgenstern, LB ;
Krieger, DW ;
Chi, TL ;
Hu, W ;
Wein, TH ;
Hardy, RJ ;
Grotta, JC ;
Buchan, AM .
STROKE, 1999, 30 (01) :34-39
[7]   Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update [J].
Derex, L. ;
Nighoghossian, N. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (10) :1093-1099
[8]   Implementation of Telemedicine and Stroke Network in Thrombolytic Administration: Comparison Between Walk-in and Referred Patients [J].
Dharmasaroja, Pornpatr A. ;
Muengtaweepongsa, Sombat ;
Kommarkg, Urai .
NEUROCRITICAL CARE, 2010, 13 (01) :62-66
[9]  
FRITSMA GA, 2002, HEMATOLOGY CLIN PRIN, P719
[10]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251